Frontlight ResearchEarly access
Taking people in SwedenPhase 1
A skin emulsion called TIR-C for adults with atopic dermatitis
Tests TIR-C skin emulsion in adults with atopic dermatitis.
Key facts
- Who runs it
- Pharmability AB
- Where
- Linkoping, Moelndal, Solna, and Uppsala, SwedenSee the 4 sites
- Trial code
- Registry title
- A double-blind, randomised, placebo-controlled first-in-human/Phase Ib trial to investigate safety, tolerability, pharmacokinetics, and preliminary efficacy of single and multiple doses of TIR-C 2% cutaneous emulsion in adults with mild to moderate atopic dermatitis
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 52 people, planned
- Started
- 14 Sept 2026
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional
- Record updated
- 5 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with mild to moderate atopic dermatitis (a long-lasting itchy skin condition). It tests TIR-C 2% cutaneous emulsion against a placebo.
- Age
- 18 years or older
- Sex
- Women and men can join.
- Disease stage
- Mild to moderate atopic dermatitis
Main reasons for not taking part
- Healthy volunteers cannot join.
Where in Sweden
- CTC Clinical Trial Consultants ABLinkoping, SwedenTaking people
- CTC Clinical Trial Consultants ABMoelndal, SwedenTaking people
- CTC Clinical Trial Consultants ABSolna, SwedenTaking people
- CTC Clinical Trial Consultants ABUppsala, SwedenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- A skin emulsion called TIR-C for adults with atopic dermatitisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 5 November 2026